Literature DB >> 9472095

Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.

M Murata1, M Tagawa, H Kimura, K Kakisawa, H Shirasawa, T Fujisawa.   

Abstract

The polymorphism of p53 gene at codon 72 consisting of either arginine (Arg)- or proline (Pro)-encoded allele is suggested to be associated with the susceptibility of tobacco-related lung cancer. In this study we examined the polymorphism of 224 non-small cell lung cancer (NSCLC) patients and that of 303 control persons with a polymerase chain reaction method and found that Pro-allele carriers were significantly more frequent in those patients who smoked and were affected at a younger age (<65) (P<0.05). We also investigated whether the mutational alterations of this gene could be influenced by the genotype. The overall mutation rate of 114 NSCLC patients examined with a single-strand conformation polymorphism method was 31%, which agreed with previous reports. However, the mutation rate was significantly increased in those patients who smoked and were affected at a younger age (<65) (P<0.05). Although the Pro-allele carriers among the smoker patients showed higher mutation rate than the Arg/Arg homozygotes, the difference between the genotypes had marginal significance (0.1<P<0.05) and was statistically insignificant, if the study was confined to younger patients. Thus, the present data cannot confirm a possible association of the p53 polymorphism with its mutation rate regarding smoking-related lung cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472095

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  P53 codon 72 polymorphism and longevity: additional data on centenarians from continental Italy and Sardinia.

Authors:  M Bonafè; F Olivieri; D Mari; G Baggio; R Mattace; M Berardelli; P Sansoni; G De Benedictis; M De Luca; F Marchegiani; L Cavallone; M Cardelli; S Giovagnetti; L Ferrucci; L Amadio; R Lisa; M G Tucci; L Troiano; G Pini; P Gueresi; M Morellini; S Sorbi; G Passeri; C Barbi; S Valensin; D Monti; L Deiana; G M Pes; C Carru; C Franceschi
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Zhi-Bin Bu; Jie Feng; Ling Peng; Xin-Biao Liao; Xin-Li Zhu; Xiao-Li Sun; Hao-Gang Yu; Dan-Fang Yan; Sen-Xiang Yan
Journal:  Mol Biol Rep       Date:  2013-11-23       Impact factor: 2.316

3.  Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study.

Authors:  Alexandra S Shadrina; Natalia A Ermolenko; Uljana A Boyarskikh; Tatiana V Sinkina; Alexandr F Lazarev; Valentina D Petrova; Maxim L Filipenko
Journal:  Clin Exp Med       Date:  2014-12-24       Impact factor: 3.984

Review 4.  The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.

Authors:  Qian Qiao; Weiguo Hu
Journal:  Lung       Date:  2013-04-18       Impact factor: 2.584

5.  Absence of germline and somatic p53 alterations in children with sporadic brain tumors.

Authors:  C Portwine; S Chilton-MacNeill; C Brown; E Sexsmith; J McLaughlin; D Malkin
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

6.  P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.

Authors:  Shengming Dai; Chen Mao; Lijun Jiang; Guisheng Wang; Hongge Cheng
Journal:  Hum Genet       Date:  2009-04-09       Impact factor: 4.132

7.  Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.

Authors:  Sanjay Katiyar; B K Thelma; N S Murthy; Suresh Hedau; Neeraj Jain; V Gopalkrishna; Syed Akhtar Husain; Bhudev C Das
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

8.  Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.

Authors:  Md Shaki Mostaid; Maizbha Uddin Ahmed; Mohammad Safiqul Islam; Muhammad Shahdaat Bin Sayeed; Abul Hasnat
Journal:  Tumour Biol       Date:  2014-07-18

9.  Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population.

Authors:  Ulku Ozbey; Hüseyin Yüce; Mustafa Namli; Tamer Elkiran
Journal:  Genet Res Int       Date:  2011-03-03

10.  TP53 Gene Polymorphisms and Occupational Skin Cancer Risks for Workers of Glass Fiber Manufacture.

Authors:  Guzel F Mukhammadiyeva; Denis O Karimov; Akhat B Bakirov; Liliya K Karimova
Journal:  Iran J Public Health       Date:  2017-11       Impact factor: 1.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.